Wir sind mit live! Mehr erfahren
LFST-Symbol

Lifestance Health

11,74 USD
-0,63
5,09 %
Zum Börsenschluss Aktualisiert 16. Okt., 16:00 EDT
Vor Börsenbeginn
Nachbörslich
11,74
0,00
0 %
1 Tag
-5,09 %
5 Tage
-5,7 %
1 Monat
-8,21 %
3 Monate
3,99 %
6 Monate
76,01 %
Seit Jahresbeginn
68,68 %
1 Jahr
132,94 %
5 Jahre
3,35 %
10 Jahre
-46,39 %
 

Profil: LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.

Mitarbeiter: 8.542

Nachrichten

Positiv
Neutral
Negativ
Stimmung 3 Monate
Positiv 50 %
Neutral 50 %
Negativ 0 %
Neutral
GlobeNewsWire
gestern
LifeStance to Host Third Quarter 2026 Earnings Conference Call on November 5, 2026
SCOTTSDALE, Ariz., Oct. 15, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental healthcare, will issue its third quarter 2026 earnings release before the market opens on Thursday, November 5, 2026.
LifeStance to Host Third Quarter 2026 Earnings Conference Call on November 5, 2026
Positiv
Zacks Investment Research
vor 4 Tagen
Take the Zacks Approach to Beat the Markets: HF Sinclair, Accenture & FirstCash in Focus
HF Sinclair, Accenture and FirstCash post impressive gains as Zacks research portfolios highlight standout performers amid market uncertainty and shifting investor sentiment.
Take the Zacks Approach to Beat the Markets: HF Sinclair, Accenture & FirstCash in Focus
Neutral
PRNewsWire
vor 16 Tagen
Nearly Half of Americans Say Fear of an Unwanted Viral Moment Keeps Them from Being Themselves in Public, LifeStance Survey Finds
Nearly 3 in 4 Gen Zers Say Fear of an Unwanted Viral Moment Affects Their Mental Health, Self-Expression and Social Participation SCOTTSDALE, Ariz., Sept. 30, 2026 /PRNewswire/ -- A LifeStance Health survey released today finds that the possibility of spontaneous, authentic moments going viral on social media is affecting people's mental well-being and reshaping behavior, self-expression and participation in everyday life.
Nearly Half of Americans Say Fear of an Unwanted Viral Moment Keeps Them from Being Themselves in Public, LifeStance Survey Finds
Neutral
The Motley Fool
vor 23 Tagen
LifeStance Health CTO Sells 42,067 Shares for $541,402
Vukasin Paunovich disposed of 42,067 shares. The transaction involved shares equal to 17% of the total stake held by the executive prior to the filing.
LifeStance Health CTO Sells 42,067 Shares for $541,402
Neutral
Seeking Alpha
letzten Monat
LifeStance Health Group, Inc. (LFST) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
LifeStance Health Group, Inc. (LFST) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
LifeStance Health Group, Inc. (LFST) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Positiv
Zacks Investment Research
letzten Monat
Here's Why LifeStance Health Group (LFST) is a Great Momentum Stock to Buy
Does LifeStance Health Group (LFST) have what it takes to be a top stock pick for momentum investors? Let's find out.
Here's Why LifeStance Health Group (LFST) is a Great Momentum Stock to Buy
Positiv
Zacks Investment Research
letzten Monat
5 Low-Leverage Stocks to Buy Amid Rising Oil Prices & Inflation Woes
Rising oil prices and inflation worries shift the spotlight to five low-leverage stocks, with strong earnings growth & balance sheets.
5 Low-Leverage Stocks to Buy Amid Rising Oil Prices & Inflation Woes
Neutral
GlobeNewsWire
letzten Monat
LifeStance Health Group Announces Pricing of Secondary Public Offering
SCOTTSDALE, Ariz., Sept. 09, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced the pricing of a secondary underwritten public offering of 22,250,000 shares of LifeStance's common stock, par value $0.01 per share (the “Common Stock”) at a public offering price of $12.35 per share, pursuant to a shelf registration statement filed with the Securities and Exchange Commission (the “SEC”) from certain stockholders of the Company (the “Selling Stockholders”). The Selling Stockholders will receive all of the proceeds from the offering. The Company is not selling any shares of Common Stock in the offering and will not receive any proceeds from the offering.
LifeStance Health Group Announces Pricing of Secondary Public Offering
Neutral
GlobeNewsWire
letzten Monat
LifeStance Health Group Announces Launch of Secondary Public Offering
SCOTTSDALE, Ariz., Sept. 09, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced that pursuant to a shelf registration statement filed with the Securities and Exchange Commission (the “SEC”), certain stockholders of the Company (the “Selling Stockholders”) intend to offer 22,250,000 shares of LifeStance's common stock, par value $0.01 per share (the “Common Stock”).
LifeStance Health Group Announces Launch of Secondary Public Offering
Positiv
Zacks Investment Research
letzten Monat
LifeStance Health Group, Inc. (LFST) Hit a 52 Week High, Can the Run Continue?
LifeStance Health (LFST) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
LifeStance Health Group, Inc. (LFST) Hit a 52 Week High, Can the Run Continue?
Kursdiagramme mit Lightweight Charts™ umgesetzt